Form 4: Invivyd Director Acquires Stock Options

Invivyd, Inc. reports that Director Terrance McGuire was granted 50,000 stock options with an exercise price of $1.04.

Summary

• Director Terrance McGuire was granted 50,000 stock options on May 19, 2026.
• The options have an exercise price of $1.04 per share.
• These options are exercisable and will vest in full on May 19, 2027, or at the Issuer's 2027 Annual Meeting of Stockholders, whichever comes first.
• Vesting is contingent upon McGuire's continuous service to the company through the vesting date.
• The options have an expiration date of May 18, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it solely reports a standard stock option grant to a director and does not provide new financial or strategic information about the company's performance.

Positives

• Grant of stock options to a director can align management's interests with shareholders.
• The exercise price of $1.04 suggests a potentially favorable entry point for the director if the stock price increases.

Negatives

• The filing only details a grant of options, not the company's financial performance or strategic updates.

Risks

• The value of the stock options is directly tied to the future performance of Invivyd, Inc.'s stock price.
• There is a risk that the stock price may not appreciate sufficiently to make the options valuable.
• The vesting condition requires continuous service, meaning departure from the company before vesting would result in forfeiture of the options.

Future Outlook

The future outlook is tied to the performance of the stock options, which depends on the company's stock price appreciation by the expiration date of May 18, 2036.

Industry Context

StockSavvy.ai notes that the grant of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, like Invivyd, Inc., to incentivize leadership and align their financial interests with long-term company growth and shareholder value.

Related Party Transactions

• The grant of stock options to Director Terrance McGuire is a related party transaction.

Stakeholder Impact

• Shareholders: The grant of options could lead to future dilution if exercised, but also aligns director incentives with stock price appreciation.
• Employees: This filing does not directly impact employees, but successful company performance, which director incentives aim to foster, benefits all stakeholders.
• Management: The options provide a financial incentive for the director to contribute to the company's success.

Next Steps

• Terrance McGuire must maintain continuous service with Invivyd, Inc. through May 19, 2027 (or the 2027 Annual Meeting of Stockholders) for the options to vest.
• The company's stock performance will determine the ultimate value of these options by May 18, 2036.

Key Dates

Keywords

Invivyd, Inc., IVVD, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act, SEC Filing